Hill-Rom Holdings ROA 2006-2018 | HRC

Current and historical return on assets (ROA) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Hill-Rom Holdings ROA for the three months ending December 31, 2018 was 7.43%.
Hill-Rom Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $0.21B $4.35B 4.66%
2018-09-30 $0.25B $4.36B 5.67%
2018-06-30 $0.23B $4.47B 5.14%
2018-03-31 $0.19B $4.51B 4.27%
2017-12-31 $0.20B $4.46B 4.39%
2017-09-30 $0.13B $4.53B 3.02%
2017-06-30 $0.12B $4.48B 2.67%
2017-03-31 $0.16B $4.47B 3.62%
2016-12-31 $0.14B $4.14B 3.39%
2016-09-30 $0.12B $4.26B 2.92%
2016-06-30 $0.06B $4.24B 1.44%
2016-03-31 $0.04B $4.24B 0.98%
2015-12-31 $0.04B $4.27B 1.31%
2015-09-30 $0.05B $4.46B 1.95%
2015-06-30 $0.08B $1.76B 4.72%
2015-03-31 $0.09B $1.71B 5.33%
2014-12-31 $0.06B $1.74B 3.70%
2014-09-30 $0.06B $1.75B 3.88%
2014-06-30 $0.07B $1.49B 4.64%
2014-03-31 $0.07B $1.52B 4.40%
2013-12-31 $0.09B $1.53B 5.96%
2013-09-30 $0.10B $1.59B 6.57%
2013-06-30 $0.11B $1.55B 6.78%
2013-03-31 $0.11B $1.57B 7.06%
2012-12-31 $0.11B $1.62B 7.61%
2012-09-30 $0.12B $1.63B 8.82%
2012-06-30 $0.15B $1.30B 11.34%
2012-03-31 $0.12B $1.29B 9.70%
2011-12-31 $0.13B $1.22B 10.34%
2011-09-30 $0.13B $1.30B 10.50%
2011-06-30 $0.12B $1.30B 9.58%
2011-03-31 $0.15B $1.28B 12.04%
2010-12-31 $0.14B $1.22B 11.46%
2010-09-30 $0.13B $1.25B 10.29%
2010-06-30 $0.10B $1.23B 8.27%
2010-03-31 $0.09B $1.22B 7.47%
2009-12-31 $-0.40B $1.20B -33.54%
2009-09-30 $-0.41B $1.23B -31.24%
2009-06-30 $-0.41B $1.17B -28.85%
2009-03-31 $-0.41B $1.17B -26.81%
2008-12-31 $0.08B $1.63B 5.13%
2008-09-30 $0.12B $1.69B 6.49%
2008-06-30 $0.14B $1.60B 7.39%
2008-03-31 $0.16B $1.64B 7.76%
2007-12-31 $0.18B $2.17B 8.78%
2007-09-30 $0.19B $2.12B 9.29%
2007-06-30 $0.21B $2.07B 10.42%
2007-03-31 $0.23B $2.04B 11.00%
2006-12-31 $0.23B $2.00B 10.88%
2006-09-30 $0.22B $1.95B 10.36%
2006-06-30 $-0.08B $2.19B -3.45%
2006-03-31 $-0.09B $2.13B -4.13%
2005-12-31 $-0.09B $2.26B -4.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.974B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Stryker (SYK) United States $69.625B 25.56
Boston Scientific (BSX) United States $55.366B 27.03
Baxter (BAX) United States $39.075B 24.08
Zimmer Biomet Holdings (ZBH) United States $25.222B 16.18
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Canopy Growth (CGC) Canada $11.042B 0.00
Bio-Rad Laboratories (BIO) United States $8.100B 51.79
Aurora Cannabis (ACB) Canada $7.040B 50.36
Perrigo (PRGO) Ireland $6.650B 10.09
Insulet (PODD) United States $5.226B 0.00
ICU Medical (ICUI) United States $5.190B 28.91
GW Pharmaceuticals (GWPH) United Kingdom $4.539B 0.00
Haemonetics (HAE) United States $4.489B 39.82
Agios Pharmaceuticals (AGIO) United States $3.462B 0.00
Hutchison China MediTech (HCM) China $3.417B 0.00
Neogen (NEOG) United States $3.281B 50.39
NuVasive (NUVA) United States $3.013B 28.03
National Vision Holdings (EYE) United States $2.624B 50.75
Quidel (QDEL) United States $2.581B 23.28
Aphria (APHA) $2.402B 106.67
NxStage Medical (NXTM) United States $1.954B 0.00
AtriCure (ATRC) United States $1.279B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.198B 23.45
Cardiovascular Systems (CSII) United States $1.170B 840.00
MacroGenics (MGNX) United States $0.923B 0.00
Cerus (CERS) United States $0.878B 0.00
PetIQ (PETQ) United States $0.837B 21.68
Surmodics (SRDX) United States $0.766B 111.39
Evolus (EOLS) United States $0.747B 0.00
NanoString Technologies (NSTG) United States $0.719B 0.00
Lantheus Holdings (LNTH) United States $0.713B 22.07
Meridian Bioscience (VIVO) United States $0.704B 20.98
OraSure Technologies (OSUR) United States $0.703B 31.03
Omeros (OMER) United States $0.688B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.625B 20.05
Quanterix (QTRX) United States $0.505B 0.00
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
TG Therapeutics (TGTX) United States $0.395B 0.00
Insys Therapeutics (INSY) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.334B 21.65
BioLife Solutions (BLFS) United States $0.299B 404.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Bovie Medical (APYX) United States $0.279B 0.00
Vapotherm (VAPO) United States $0.276B 0.00
Cytosorbents (CTSO) United States $0.262B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 7.65
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.091B 18.98
Female Health (VERU) United States $0.084B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Conatus Pharmaceuticals (CNAT) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 13.57